The Assessment of Life Style and the Visceral Adiposity Index as Cardiometabolic Risk Factors

Gârgavu, Sigina R.; Clenciu, Diana; Roșu, Maria M.; Cojan, Tiberiu Ștefăniță Țenea; Costache, Andrei; Vladu, Ionela Mihaela; Mota, Maria Paula

doi:10.31688/abmu.2018.53.2.02

Cited by 3 publications

(3 citation statements)

References 5 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Age, male sex, type 2 diabetes mellitus (T2DM), obesity, hypertension, heart failure and metabolic syndrome are some of the risk factors involved in the development of AF (3)(4)(5). The relationship between T2DM and AF is complex and of particular interest.…”

Section: Introductionmentioning

confidence: 99%

Cardio metabolic risk factors for atrial fibrillation in type 2 diabetes mellitus: Focus on hypertension, metabolic syndrome and obesity

Găman¹,

Dobrică²,

Pascu³

et al. 2019

JMMS

View full text Add to dashboard Cite

Objective. Atrial fibrillation (AF) in type 2 diabetes mellitus (T2DM) has been little explored so far. However, there are several cardio metabolic risk factors for AF in T2DM patients, such as arterial hypertension, obesity or the metabolic syndrome. Our objective was to evaluate cardio metabolic risk factors for AF in T2DM patients. Methods. We studied the medical records of T2DM patients hospitalized in the Internal Medicine department of an emergency referral hospital in Bucharest, Romania. The study was observational, retrospective and carried out between January-June 2018. Results. The study group included 221 T2DM patients (with a mean age of 68.65 ± 10.64, ranging between 37-93 years): 116 women (52.49%; with a mean age of 70.53 ± 10.69, ranging between 37-93 years) and 105 men (47.51%; with a mean age of 66.57 ± 10.23, ranging between 38-91 years). 92 patients had AF (41.63%): 40 women (34.48%) and 52 men (49.52%). 180 patients (81.45%) were hypertensive: 103 women (88.79%) and 77 men (73.33%). 113 patients (51.13%) had metabolic syndrome: 58 women (50.00%) and 55 men (52.38%). 77 patients (34.84%) were obese: 45 women (38.79%) and 32 men (30.48%). AF patients associated obesity in 26 cases (28.26%), hypertension in 73 cases (79.35%) and metabolic syndrome in 56 cases (60.87%). Conclusions. Out of the study group, 92 T2DM patients (41.63%) had AF, men being more likely to suffer from AF than women (p=0.0288). Hypertension affected 180 patients (81.45%) and in greater proportion women vs. men (p=0.0051). The metabolic syndrome and obesity were discovered in 113 patients (51.13%) and 77 patients (34.84%), respectively, with no significant differences in terms of gender. In our research, the highest cardio metabolic risk factors for AF in T2DM were hypertension (OR = 3.6675) and the metabolic syndrome (OR = 3.3388).

show abstract

Section: Introductionmentioning

confidence: 99%

Cardio metabolic risk factors for atrial fibrillation in type 2 diabetes mellitus: Focus on hypertension, metabolic syndrome and obesity

Găman¹,

Dobrică²,

Pascu³

et al. 2019

JMMS

View full text Add to dashboard Cite

show abstract

“…It should be noted that in all experimental groups that received quercetin solutions as a preparation for correcting DM (except for the initial bioflavonoid), the concentration of corticosterone significantly decreased compared to the same indicator of rats that did not receive the drug -Group 2 (Table 3). Disorders of carbohydrate metabolism are usually accompanied by changes in lipid, protein, and mineral metabolism, [24][25][26] therefore, at the next stage of the work it was important to assess the content of some integral biochemical plasma parameters reflecting these types of metabolism in rats with an alloxan model of DM before and after taking quercetin solutions. Analysis of the data showed that quercetin had no effect on the concentration of the main metabolites of healthy animals (control).…”

Section: Resultsmentioning

confidence: 99%

Experimental substantiation of the use of quercetin for the correction of functional disorders in diabetes mellitus

AP¹,

GA²,

IO³

et al. 2022

MOJAP

View full text Add to dashboard Cite

The diabetes mellitus is an acute medical and social problem demanding the search of different methods of carbohydrate metabolism correction. The literature data during the last years indicate that parallel with medical drugs the protective and medicinal effects could provide herbal preparations. To test the hypothesis of the effect of one of them – quercetin in different forms - on the carbohydrate metabolism this study has been done. It has been shown that the initial, adsorbed and encapsulated quercetin in a cellulose molecule had a pronounced effect on some parameters of carbohydrate, fat and protein metabolism in rats compared with animals that did not receive this bioflavonoid. The initial quercetin showed a distinct, but short-term, hypoglycemic effect already on the 1-st day of the study, while the surface-adsorbed and cellulose-encapsulated quercetin had a significant effect starting from the 5-th day, but this effect persisted throughout the observation. These hypoglycemic effects of quercetin partly due to the increase of glycogen in the liver and elevation of plasma corticosterone. The other possible mechanisms of quercetin effect on glucose concentration in plasma are proposed.

show abstract

“…Non-rational eating behavior in the form of external and emotional types is likely to lead to energy saving in the body and to favor the occurrence and progression of hypertension [19][20] . On the other hand, an insufficient amount of fiber, vegetables, and fruits in the diet leads to IBS-C [21][22][23] .…”

Section: Discussionmentioning

confidence: 99%

Ghrelin level and types of eating behavior when combined with irritable bowel syndrome, arterial hypertension and obesity

MISCHUK¹,

Grygoruk²,

Stupnytska³

et al. 2018

Arch Balk Med Union

View full text Add to dashboard Cite

Le niveau de la ghréline et les types d'habitude alimentaire lors de la combinaison du syndrome de l'intestin irritable, de l'hypertension artérielle et de l'obésité Contexte. La ghréline régule la motilité du tractus gastro-intestinal, la nature du comportement alimentaire, a un effet cardioprotecteur, augmente la vasodilatation et régule la tension artérielle. Objectif. Etudier le niveau de la ghréline basale et postprandiale chez les patients présentant une combinaison de l'hypertension, le syndrome du côlon irritable sur le fond de l'obésité et du comportement alimentaire. Méthodes. L'étude a porté sur 24 patients avec syndrome du côlon irritable, constipation, poids normal, 18 patients avec de l'hypertension de 2-ème degré sur le fond de l'obésité et 54 patients souffrant de troubles concomitants (syndrome du côlon irritable avec constipation sur le fond de l'hypertension et l'obésité I-III).

show abstract

The Assessment of Life Style and the Visceral Adiposity Index as Cardiometabolic Risk Factors

Cited by 3 publications

References 5 publications

Cardio metabolic risk factors for atrial fibrillation in type 2 diabetes mellitus: Focus on hypertension, metabolic syndrome and obesity

Cardio metabolic risk factors for atrial fibrillation in type 2 diabetes mellitus: Focus on hypertension, metabolic syndrome and obesity

Experimental substantiation of the use of quercetin for the correction of functional disorders in diabetes mellitus

Ghrelin level and types of eating behavior when combined with irritable bowel syndrome, arterial hypertension and obesity

Contact Info

Product

Resources

About